ConductScience.org, home

Paper37065752

Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.

Chertok Shacham E and 6 others. Front Endocrinol (Lausanne), 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level. Papers, record 37065752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37065752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
PubMed
Journal
Front Endocrinol (Lausanne)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.82
iCite
Revised in PubMed
2023-04-24
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chertok Shacham EElena
2Maman NNimra
3Lazareva TTatyana
4Masalha RRefaat
5Mahagna LLila
6Sela GGala
7Ishay AAvraham

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hyperparathyroidism, PrimaryMajor topic
HypercalcemiaMajor topic
Humans
Calcium
Fibroblast Growth Factor-23
Vitamin D
Calcifediol

Source PubMed

Download CSV of topics

References27

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120685823PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.Am J Physiol Renal Physiol2010https://conductscience.org/library/papers/20685823PubMed
232803112Normocalcemic Hyperparathyroidism: A Heterogeneous Disorder Often Misdiagnosed?JBMR Plus2020https://conductscience.org/library/papers/32803112PubMed
315248822Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism.Eur J Endocrinol2004https://conductscience.org/library/papers/15248822PubMed
417554146Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.J Am Soc Nephrol2007https://conductscience.org/library/papers/17554146PubMed
523677793Association of serum fibroblast growth factor 23 (FGF23) and incident fractures in older men: the Osteoporotic Fractures in Men (MrOS) study.J Bone Miner Res2013https://conductscience.org/library/papers/23677793PubMed
632598019FGF23 and primary hyperparathyroidism: is there a link?Endokrynol Pol2020https://conductscience.org/library/papers/32598019PubMed
730665550Management of normocalcemic primary hyperparathyroidism.Best Pract Res Clin Endocrinol Metab2018https://conductscience.org/library/papers/30665550PubMed
834860179Perioperative changes of FGF23 in patients undergoing surgery for primary hyperparathyroidism.Endocr Connect2022https://conductscience.org/library/papers/34860179PubMed
926332755Clinical Expression of Calcium Sensing Receptor Polymorphism (A986S) in Normocalcemic and Asymptomatic Hyperparathyroidism.Horm Metab Res2016https://conductscience.org/library/papers/26332755PubMed
1034300255Assessment of Clinical Utility of Assaying FGF-23, Klotho Protein, Osteocalcin, NTX, and Sclerostin in Patients with Primary Hyperparathyroidism.J Clin Med2021https://conductscience.org/library/papers/34300255PubMed
1117565275Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.Curr Opin Nephrol Hypertens2007https://conductscience.org/library/papers/17565275PubMed
1212711740Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.N Engl J Med2003https://conductscience.org/library/papers/12711740PubMed
1332606893Evaluation of Serum Level of FGF23 and 1,25(OH)2D3 in Primary Hyperparathyroidism Patients Before and After Parathyroidectomy.Int J Gen Med2020https://conductscience.org/library/papers/32606893PubMed
1433015068Disorders of Calcium and Phosphorus Metabolism and the Proteomics/Metabolomics-Based Research.Front Cell Dev Biol2020https://conductscience.org/library/papers/33015068PubMed
1527498418Fgf23 and parathyroid hormone signaling interact in kidney and bone.Mol Cell Endocrinol2016https://conductscience.org/library/papers/27498418PubMed
1621984611Increased circulating levels of FGF23: an adaptive response in primary hyperparathyroidism?Eur J Endocrinol2012https://conductscience.org/library/papers/21984611PubMed
1735380024Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.J Korean Med Sci2022https://conductscience.org/library/papers/35380024PubMed
1831557077LOW FREE (BUT NOT TOTAL) 25-HYDROXYVITAMIN D LEVELS IN SUBJECTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.Endocr Pract2020https://conductscience.org/library/papers/31557077PubMed
1932072184Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.J Clin Endocrinol Metab2020https://conductscience.org/library/papers/32072184PubMed
2023700148Dosage effect of a Phex mutation in a murine model of X-linked hypophosphatemia.Calcif Tissue Int2013https://conductscience.org/library/papers/23700148PubMed

See all 27 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
40949872Comparative analysis of blood whole transcriptome profiles in Yili horses pre- and post-5000-meter racing.Front Genet2025https://conductscience.org/library/papers/40949872PubMed
39518465Osteoporosis and Normocalcemic Primary Hyperparathyroidism (Conservatively or Surgically Managed).J Clin Med2024https://conductscience.org/library/papers/39518465PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37065752

GET https://conductscience.org/api/papers/v1/37065752/references?page=2